Cannabis Law Report
AUGUST 12, 2019
Cannabis advertising alone is a regulatory concern, and in-house counsel should play a role in their company’s advertising policies to avoid hefty fines and other consequences, according to in-house and law firm lawyers who practice in the growing cannabis industry. Here’s the introduction to the piece.
Cannabis Law Report
SEPTEMBER 11, 2021
The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. This may include developing new methods, policies, and procedures to further program goals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
MARCH 2, 2024
Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. Ohio Cannabis Dispensary Regulations Dispensaries must adhere to strict regulations set forth by the Ohio Medical Marijuana Control Program to ensure compliance and patient safety.
Cannabis Law Report
MAY 26, 2022
ICPR 2022 will showcase the latest findings in psychedelic science, novel approaches in psychedelic therapy, and feature developments in policy, consciousness research, neuroscience, philosophy, and much more. ICPR 2022 will feature over a hundred experts from psychiatry, healthcare policy, neuroscience, the humanities, and pharmacology.
MMJ Recs
MARCH 16, 2024
Regulatory Framework and Policy Implications The regulatory framework governing the medical marijuana industry has profound implications for businesses, consumers, and society as a whole. Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols.
Cannabis Law Report
JUNE 15, 2021
The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission. This may include developing new methods, policies, and procedures to further program goals.
Cannabis Law Report
MAY 18, 2022
The majority of conversations at the Medical Psychedelics House of Davos will focus on regulatory approval for these compounds, their therapeutic potential, policy, safety and efficacy, biocultural preservation, drug development pipelines, and patient access.
Expert insights. Personalized for you.
55 
Let's personalize your content